Greenbrae, CA, United States of America

Miles Trupp

This inventor holds 1 USPTO granted patent. Top assignee: Licentia, Ltd.. Active years: 2004.


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2004

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Miles Trupp: Innovator in Neurotrophic Factor Research

Introduction

Miles Trupp is a notable inventor based in Greenbrae, CA (US). He has made significant contributions to the field of neurobiology, particularly in the study of glial cell line-derived neurotrophic factors. His work has implications for understanding and treating various neurological conditions.

Latest Patents

Miles Trupp holds a patent for "Assays using glial cell line-derived neurotrophic factor receptors." This patent discloses receptors for Glial Cell Line-Derived Neurotrophic Factor (GDNF), detailing their cellular expression, isolation, biochemical characterization, and sequences. The patent highlights c-RET as one receptor for GDNF, along with additional novel receptors. Furthermore, it includes the preparation of monoclonal antibodies directed against GDNF.

Career Highlights

Miles Trupp is associated with Licentia, Ltd., where he continues to advance research in neurotrophic factors. His innovative work has garnered attention in the scientific community, contributing to the understanding of neurotrophic signaling pathways.

Collaborations

Miles has collaborated with esteemed colleagues such as Mart Saarma and Carlos F Ibanez. Their joint efforts have furthered research in the field and have led to significant advancements in neurobiology.

Conclusion

Miles Trupp is a prominent figure in the realm of neurotrophic factor research, with a patent that showcases his innovative contributions. His work continues to influence the scientific community and holds promise for future advancements in neurological therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…